These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 23679075

  • 21. Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD).
    Nicastro N, Burkhard PR, Garibotto V.
    Mol Imaging Biol; 2020 Dec; 22(6):1592-1599. PubMed ID: 32468408
    [Abstract] [Full Text] [Related]

  • 22. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.
    Benítez-Rivero S, Marín-Oyaga VA, García-Solís D, Huertas-Fernández I, García-Gómez FJ, Jesús S, Cáceres MT, Carrillo F, Ortiz AM, Carballo M, Mir P.
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618
    [Abstract] [Full Text] [Related]

  • 23. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
    Kahraman D, Eggers C, Holstein A, Schneider C, Pedrosa DJ, Dietlein M, Kobe C, Timmermann L, Schmidt M.
    Nuklearmedizin; 2012 Feb; 51(6):244-51. PubMed ID: 22526237
    [Abstract] [Full Text] [Related]

  • 24. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.
    Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, van Royen EA.
    Eur J Nucl Med; 1997 Jan; 24(1):68-71. PubMed ID: 9044880
    [Abstract] [Full Text] [Related]

  • 25. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
    Lorberboym M, Treves TA, Melamed E, Lampl Y, Hellmann M, Djaldetti R.
    Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
    [Abstract] [Full Text] [Related]

  • 26. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study.
    Ceravolo R, Volterrani D, Gambaccini G, Bernardini S, Rossi C, Logi C, Tognoni G, Manca G, Mariani G, Bonuccelli U, Murri L.
    J Neural Transm (Vienna); 2004 Aug; 111(8):1065-73. PubMed ID: 15254794
    [Abstract] [Full Text] [Related]

  • 27. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J, de Jong J, de Bruin K, Knol R, de Win MM, van Eck-Smit BL.
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [Abstract] [Full Text] [Related]

  • 28. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
    Lee H, Sung YH, Hwang KH.
    Curr Med Imaging; 2023 Mar; 19(9):1041-1051. PubMed ID: 36734891
    [Abstract] [Full Text] [Related]

  • 29. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD, Svetel MV, Kostic VS, Sobic-Saranovic DP, Pavlovic SV, Artiko VM, Obradovic VB.
    Hell J Nucl Med; 2012 Mar; 15(2):134-8. PubMed ID: 22833860
    [Abstract] [Full Text] [Related]

  • 30. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS, Jeong JM, Park SS, Kim JM, Chang YS, Song HC, Kim KM, Yoon KY, Lee MC, Lee SB.
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [Abstract] [Full Text] [Related]

  • 31. Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.
    Apostolova I, Taleb DS, Lipp A, Galazky I, Kupitz D, Lange C, Makowski MR, Brenner W, Amthauer H, Plotkin M, Buchert R.
    Clin Nucl Med; 2017 Aug; 42(8):589-594. PubMed ID: 28574876
    [Abstract] [Full Text] [Related]

  • 32. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N, Otsuka H, Shinya T, Otomi Y, Harada M, Sako W, Izumi Y, Kaji R, Watanabe Y, Takashi S, Kunikane Y.
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [Abstract] [Full Text] [Related]

  • 33. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
    Roselli F, Pisciotta NM, Perneczky R, Pennelli M, Aniello MS, De Caro MF, Ferrannini E, Tartaglione B, Defazio G, Rubini G, Livrea P.
    Mov Disord; 2009 Oct 30; 24(14):2097-103. PubMed ID: 19705471
    [Abstract] [Full Text] [Related]

  • 34. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, Janssen AG, Van Royen EA.
    Synapse; 1997 Nov 30; 27(3):183-90. PubMed ID: 9329154
    [Abstract] [Full Text] [Related]

  • 35. Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation.
    Sogorb-Esteve A, Swift IJ, Woollacott IOC, Warren JD, Zetterberg H, Rohrer JD.
    J Neuroinflammation; 2021 Oct 03; 18(1):224. PubMed ID: 34602080
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
    Kraemmer J, Kovacs GG, Perju-Dumbrava L, Pirker S, Traub-Weidinger T, Pirker W.
    Mov Disord; 2014 Dec 03; 29(14):1767-73. PubMed ID: 25048738
    [Abstract] [Full Text] [Related]

  • 38. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ, Firbank MJ, Pakrasi S, Lloyd JJ, Driver I, McKeith IG, Williams ED, O'Brien JT.
    Int Psychogeriatr; 2008 Dec 03; 20(6):1124-40. PubMed ID: 18752700
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A, Payoux P, Habert MO, Malek Z, Cointepas Y, El Fakhri G, Chaumet-Riffaud P, Itti E, Remy P.
    J Nucl Med; 2007 Sep 03; 48(9):1459-67. PubMed ID: 17704252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.